Keith L Black Selected Research

Keith L Black Research Topics

Disease

99	Neoplasms (Cancer) 06/2023 - 01/2002
67	Glioma (Gliomas) 06/2023 - 01/2002
42	Brain Neoplasms (Brain Tumor) 10/2021 - 06/2002
36	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 12/2002
25	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 12/2009
12	Cognitive Dysfunction 02/2024 - 03/2014
10	Breast Neoplasms (Breast Cancer) 04/2015 - 11/2003
7	Amyloid Plaque 02/2024 - 01/2011
7	Inflammation (Inflammations) 01/2022 - 07/2014
6	Amyloidosis 01/2022 - 01/2020
6	Disease Progression 01/2022 - 01/2011
4	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2023 - 01/2020
4	Gliosis 10/2020 - 12/2009
4	Lung Neoplasms (Lung Cancer) 05/2015 - 01/2007
3	Tauopathies 02/2024 - 12/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 03/2009
3	Meningioma (Meningiomas) 01/2023 - 08/2003
3	Astrocytoma (Pilocytic Astrocytoma) 04/2020 - 08/2004
3	Gliosarcoma 09/2008 - 07/2007
2	Brain Injuries (Brain Injury) 01/2024 - 01/2018
2	Oligodendroglioma 04/2020 - 05/2014
2	Neuroinflammatory Diseases 01/2020 - 01/2019
2	Wounds and Injuries (Trauma) 03/2016 - 02/2010
2	Triple Negative Breast Neoplasms 12/2013 - 01/2012
2	Carcinogenesis 11/2010 - 02/2007

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2003
19	Retinaldehyde (Retinal)IBA 02/2024 - 01/2011
17	VaccinesIBA 06/2023 - 05/2004
17	Amyloid (Amyloid Fibrils)IBA 01/2023 - 12/2009
13	AntigensIBA 01/2024 - 07/2003
13	Neoplasm Antigens (Tumor Antigens)IBA 06/2023 - 03/2003
10	poly(malic acid)IBA 01/2019 - 01/2006
10	Antisense OligonucleotidesIBA 06/2014 - 10/2003
9	malic acid (malate)IBA 01/2023 - 03/2006
9	NanoconjugatesIBA 01/2022 - 03/2006
8	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 08/2005
8	CytokinesIBA 01/2019 - 01/2002
7	Peptides (Polypeptides)IBA 01/2022 - 02/2004
7	laminin 8IBA 10/2007 - 10/2003
6	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 11/2011
6	Monoclonal AntibodiesIBA 01/2012 - 06/2003
6	MorpholinosIBA 01/2012 - 10/2003
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2004
5	PolymersIBA 10/2021 - 01/2008
5	Laminin (Merosin)IBA 10/2012 - 10/2003
5	Messenger RNA (mRNA)IBA 02/2011 - 01/2003
5	polycefinIBA 04/2008 - 01/2006
4	Protein Isoforms (Isoforms)IBA 02/2024 - 08/2004
4	CurcuminIBA 01/2020 - 09/2015
4	Transferrin Receptors (Transferrin Receptor)IBA 01/2012 - 01/2006
4	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 06/2003
4	PotassiumIBA 09/2008 - 06/2002
4	CalciumIBA 09/2008 - 06/2002
4	NS 1619IBA 08/2008 - 06/2002
4	BradykininIBA 03/2007 - 06/2002
3	Amyloid beta-PeptidesIBA 11/2023 - 12/2009
3	Particulate MatterIBA 10/2023 - 11/2013
3	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2006
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2023 - 03/2014
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
3	Contrast MediaIBA 01/2020 - 05/2015
3	GadoliniumIBA 01/2020 - 01/2013
3	AntibodiesIBA 01/2019 - 10/2007
3	Biopolymers (Biopolymer)IBA 01/2019 - 03/2006
3	ErbB Receptors (EGF Receptor)IBA 12/2016 - 10/2012
3	Green Fluorescent ProteinsIBA 08/2015 - 06/2003
3	EnzymesIBA 09/2014 - 09/2008
3	Cancer VaccinesIBA 09/2014 - 02/2004
3	ProdrugsIBA 04/2013 - 11/2010
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2012 - 11/2002
3	DNA (Deoxyribonucleic Acid)IBA 05/2009 - 04/2004
3	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 03/2007 - 06/2002
3	InterleukinsIBA 09/2006 - 10/2002
3	laminin 9IBA 01/2006 - 08/2004
3	Carboplatin (JM8)FDA LinkGeneric 08/2005 - 06/2003
2	Neuraminidase (Sialidase)IBA 06/2023 - 09/2014
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 06/2023 - 09/2014
2	DisulfidesIBA 01/2023 - 03/2006
2	leucyl-leucyl-leucineIBA 01/2023 - 10/2010
2	Small Interfering RNA (siRNA)IBA 01/2023 - 06/2004
2	epidermal growth factor receptor VIIIIBA 10/2021 - 12/2016
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2007
2	Therapeutic UsesIBA 08/2015 - 09/2009
2	CamptothecinIBA 04/2013 - 09/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 09/2008
2	Nucleosomes (Nucleosome)IBA 01/2012 - 10/2007
2	Complementary DNA (cDNA)IBA 11/2011 - 12/2002
2	Trastuzumab (Herceptin)FDA Link 02/2011 - 04/2010
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011 - 09/2008

Therapy/Procedure

39	Therapeutics 01/2023 - 03/2002
19	Drug Therapy (Chemotherapy) 01/2023 - 11/2003
17	Immunotherapy 06/2023 - 03/2003
6	Radiotherapy 01/2023 - 05/2004
6	Lasers (Laser) 01/2020 - 07/2004
4	Adjuvant Radiotherapy 06/2016 - 07/2005
3	Oral Administration 04/2010 - 06/2008
2	Immunomodulation 10/2020 - 12/2009
2	Intravenous Injections 01/2020 - 10/2007
2	Craniotomy 03/2016 - 08/2012